Evidence map›Paper›PMID 31352568›Full record

ReviewDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2019

Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.

Rozita Naseri, Fatemeh Farzaei, Sajad Fakhri, Fardous F El-Senduny, Miram Altouhamy, Roodabeh Bahramsoltani, Farnaz Ebrahimi, Roja Rahimi, Mohammad Hosein Farzaei

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05172947 (Impact of Resveratrol and Pharmaceutical Care on Diabetes Mellitus and Its Neuropathic Complication), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05172947 nacompletednot on this mapstarted 2021, after this paper: background citation

Impact of Resveratrol and Pharmaceutical Care on Diabetes Mellitus and Its Neuropathic Complication

TypeinterventionalSponsorUniversity of SulaimaniRan2021 to 2022Enrolled120ConditionsDiabetic NeuropathiesArmsResveratrol, Placebo, Resveratrol plus Pharmaceutical care, Placebo+Pharmaceutical care
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Phytochemical Constituents and Derivatives ofInternational journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Different Fruit-Specific Promoters DriveMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rozita NaseriFaculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Fatemeh FarzaeiPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Sajad FakhriPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Fardous F El-SendunyBiochemistry division, Chemistry Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Miram AltouhamyBiochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Roodabeh BahramsoltaniDepartment of Pharmacy in Persian Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Farnaz EbrahimiPharmacy students` research committee, School of pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Roja RahimiDepartment of Pharmacy in Persian Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Hosein FarzaeiPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. mh.farzaei@gmail.com.ORCID http://orcid.org/0000-0001-7081-6521
Kermanshah University of Medical Sciences · IRUniversal Scientific Education and Research Network · IRAin Shams University · EGIsfahan University of Medical Sciences · IRMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDiabetic neuropathy (DNP) is a widespread and debilitating complication with complex pathophysiology that is caused by neuronal dysfunction in diabetic patients. Conventional therapeutics for DNP are quite challenging due to their serious adverse effects. Hence, there is a need to investigate novel effective and safe options. The novelty of the present study was to provide available therapeutic approaches, emerging molecular mechanisms, signaling pathways and future directions of DNP as well as polyphenols' effect, which accordingly, give new insights for paving the way for novel treatments in DNP. EVIDENCE ACQUISITION: A comprehensive review was done in electronic databases including Medline, PubMed, Web of Science, Scopus, national database (Irandoc and SID), and related articles regarding metabolic pathways on the pathogenesis of DNP as well as the polyphenols' effect. The keywords "diabetic neuropathy" and "diabetes mellitus" in the title/abstract and "polyphenol" in the whole text were used. Data were collected from inception until May 2019.

resultsDNP complications is mostly related to a poor glycemic control and metabolic imbalances mainly inflammation and oxidative stress. Several signaling and molecular pathways play key roles in the pathogenesis and progression of DNP. Among natural entities, polyphenols are suggested as multi-target alternatives affecting most of these pathogenesis mechanisms in DNP.

conclusionThe findings revealed novel pathogenicity signaling pathways of DNP and affirmed the auspicious role of polyphenols to tackle these destructive pathways in order to prevent, manage, and treat various diseases. Graphical Abstract .

Indexed as

Diabetic NeuropathiesHumansOxidative StressPolyphenolsRandomized Controlled Trials as TopicSignal TransductionTreatment OutcomePolyphenolsDiabetic neuropathyPolyphenolsSignaling pathwaysTherapeutic targets

Identifiers

PMID31352568
PMCPMC6895369
OpenAlexW2965116159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.